Direct mediastinal injection of DDS-CDDP prohibited local recurrence in the mediastinum in advanced esophageal cancer patients
スポンサーリンク
概要
- 論文の詳細を見る
Direct mediastinal injection of Cisplatin (CDDP) with activated charcoal or of CDDP powder with Lipiodol (DDS-CDDP) was performed in advanced esophageal cancer patients (Stage III and IV) from 1989 to 1995. Curative tumor resection with extended lymphadenectomy was performed in 45 cases, and 22 patients received the direct mediastinal injection (DMI) combined with additional postoperative systemic chemotherapy (DMI group); these two treatments were assigned by block randomization. CDDP was injected into the mediastinum in two forms: CDDP+FM127 (activated charcoal) and CDDP powder+Lipiodol. Complications related to mediastinal injection occurred in only 1 patient (mediastinitis). Mediastinal local recurrence was not determined in patients with DMI treatment. In conclusion, direct injection of DDS-CDDP to the mediastinum might be a safe and effective postoperative treatment for prevention of local recurrence in the mediastinum.
- 日本癌病態治療研究会の論文
日本癌病態治療研究会 | 論文
- Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy
- Endoscopic Mucosal Resection (EMR) for Colorectal Lesions and Lesion-lifted Condition as an Indicator of the Tumor Invasion
- NOVEL APPROACH TO IMMUNOTHERAPY FOR EPITHELIAL CANCERS, BONE AND SOFT-TISSUE SARCOMAS
- Extracellular heat shock proteins (eHSPs) pilot exogenous antigen into cross-presentation pathway: A superguide from extracellular world to intracellular tour
- Preoperative body mass index and outcomes of gastric cancer patients